| ★ |  Alternative Endpoints for and Approaches to Metabolic Health, With Daria Igudesman, PhD, MS | | 5 | Estados Unidos | |
| 3 |  Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health | Metabolic Mind @metabolicmind | — | Estados Unidos | 89 |
| 19 |  Q&A: Cholesterol, CRP, & Ketogenic Therapy — A Cardiologist Weighs In | Metabolic Mind @metabolicmind | — | Estados Unidos | 87 |
| 20 |  Breaking Down the 2025 Dietary Guidelines with Dr. David Ludwig & Gary Taubes | Metabolic Mind @metabolicmind | — | Estados Unidos | 87 |
| 2 |  GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals | Metabolic Mind @metabolicmind | 49.3K | Estados Unidos | 89 |
| 8 |  A New Approach To GLP-1s | Metabolic Mind @metabolicmind | 5.6K | Estados Unidos | 88 |
| 6 |  Ketogenic Therapy in Psychiatry: What the Experts Agree On | Metabolic Mind @metabolicmind | 5.2K | Estados Unidos | 88 |
| 15 |  Muscle, metabolism & GLP-1s | Rocio Salas-Whalen, M.D. | the mindbodygreen podcast @mindbodygreen | 3.4K | Estados Unidos | 88 |
| 7 |  Do GLP-1s Work for Depression—or Is It Metabolism? | Metabolic Mind @metabolicmind | 2.5K | Estados Unidos | 88 |
| 17 |  How to Actually Assess Your Heart Risk @metabolicmind #hearthealth #lowcarb #keto | Max Helmer The Low Carb Consultant @maxhelmerthelowcarbconsult1125 | 1.7K | — | 87 |
| 5 |  Is Keto Making You Sicker? Here’s a Better Way to Heal | Montgomery Heart & Wellness @montgomeryheartwellness | 1.6K | Estados Unidos | 88 |
| 18 |  Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 87 |
| 1 |  Dietary Interventions to Slow Metabolic Deterioration in Menopausal Patients | | 175 | Estados Unidos | 89 |
| 11 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 88 |
| 14 |  Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes | | 143 | Estados Unidos | 88 |
| 4 |  Better Benefits, Better Health: Tackling Diabetes and Obesity | | 118 | Estados Unidos | 89 |
| 12 |  Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS | | 94 | Estados Unidos | 88 |
| 13 |  Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 88 |
| 9 |  Diabetes Dialogue: Signos and the Science of Weight Loss | | 75 | Estados Unidos | 88 |
| 10 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 88 |
| 16 |  Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 88 |